Clinical trial
Phase 2 Study Evaluation of Topical 10% Metronidazole Ointment for the Reduction of Pain After Haemorrhoidectomy
NCT00774722 is registered in ClinicalTrials.gov with S.L.A. Pharma AG as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Phase 2 Study Evaluation of Topical 10% Metronidazole Ointment for the Reduction of Pain After Haemorrhoidectomy
- Lead sponsor
- S.L.A. Pharma AG
- Phase
- Phase 2/3
- Overall status
- Completed
- Start date
- September 30, 2006
- Completion date
- March 31, 2008
- Enrollment
- 59 (actual)
- Sites
- 5
Conditions
As the registry lists them; a condition with its own page is linked.
haemorrhoidectomy